Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders
Lihong Guan, Yawei Han, Ciqing Yang, et al.
Molecular Neurobiology (2021) Vol. 59, Iss. 2, pp. 968-982
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs
Ana Rita Monteiro, Daniel José Barbosa, Fernando Remião, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115522-115522
Open Access | Times Cited: 126
Advancements in Surgical Therapies for Drug-Resistant Epilepsy: A Paradigm Shift towards Precision Care
Zhong Chen, Kang Yang, Nianhua Wang, et al.
Neurology and Therapy (2025)
Open Access | Times Cited: 2
CRISPR/Cas9 Mediated Therapeutic Approach in Huntington’s Disease
Süleyman Serdar Alkanlı, Nevra Alkanlı, Arzu Ay, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 3, pp. 1486-1498
Open Access | Times Cited: 45
Stem cell therapeutics and gene therapy for neurologic disorders
Kevin S. Chen, Emily J. Koubek, Stacey A. Sakowski, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00427-e00427
Open Access | Times Cited: 10
Revisiting Alpha-Synuclein Pathways to Inflammation
Patrícia Lyra, Vanessa Machado, Silvia Rota, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7137-7137
Open Access | Times Cited: 16
Advances in stem cell and other therapies for Huntington’s disease: An update
L. A. Conner, Bhairavi Srinageshwar, Bakke Jl, et al.
Brain Research Bulletin (2023) Vol. 199, pp. 110673-110673
Open Access | Times Cited: 12
ALZHEIMER'S DISEASE: COMPREHENSIVE INSIGHTS INTO RISK FACTORS, BIOMARKERS, AND ADVANCED TREATMENT APPROACHES
Suresh Janadri, SHREELAXMI DADMI, Manjunatha P. Mudagal, et al.
International Journal of Current Pharmaceutical Research (2025), pp. 1-10
Open Access
Exploratory analysis of a Novel RACK1 mutation and its potential role in epileptic seizures via Microglia activation
Sai Zhang, Zhaofei Dong, Jiafu Ji, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Nanoengineered, ultrasmall and catalytic potassium calcium hexacyanoferrate for neuroprotection and temporal lobe epilepsy treatment
Shini Feng, Wei Qiao, Lili Xia, et al.
Science Bulletin (2025)
Closed Access
Lymphoblastoid and Jurkat cell lines are useful surrogate in developing a CRISPR-Cas9 method to correct leukocyte adhesion deficiency genomic defect
A. Ramadan, Noureddine Ben Khalaf, Khaled Trabelsi, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects
Mohamad Sultan Khan, Nousheen Qureshi, Rehan Khan, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Application of CRISPR-Cas9 in microbial cell factories
Jinhui Yang, Junyan Song, Zeyu Feng, et al.
Biotechnology Letters (2025) Vol. 47, Iss. 3
Closed Access
Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies
Amrutha Banda, Olivia Impomeni, Aparana Singh, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 636-636
Open Access | Times Cited: 3
Neuroprotective potential of Epigenetic modulators, its regulation and therapeutic approaches for the management of Parkinson's disease
Shobha Kumari, Sakshi Gupta, Rajesh Sukhija, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177123-177123
Closed Access | Times Cited: 3
Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery
Yu Wu, Miora Rakotoarisoa, Borislav Angelov, et al.
Nanomaterials (2022) Vol. 12, Iss. 13, pp. 2267-2267
Open Access | Times Cited: 12
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Leyao Li, Lakshmy Vasan, Bryan Kartono, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2725-2725
Open Access | Times Cited: 7
Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy
Dongdong Tang, Yan Yang, Yangyang Li, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 203-219
Open Access | Times Cited: 7
Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment
Xinpu Yang, Thuỳ Anh Bùi, Haoqi Mei, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 38
Closed Access | Times Cited: 2
A Comprehensive Overview of the Current Status and Advancements in Various Treatment Strategies against Epilepsy
Abdul Waris, Muhammad Siraj, Ayyaz Ali Khan, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3729-3757
Open Access | Times Cited: 2
The bHLH Transcription Factors in Neural Development and Therapeutic Applications for Neurodegenerative Diseases
Dong Gi Lee, Young-Kwang Kim, Kwang‐Hyun Baek
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13936-13936
Open Access | Times Cited: 10
Current and promising therapeutic options for Dravet syndrome
Antonella Riva, Gianluca D’Onofrio, Elisabetta Amadori, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 15, pp. 1727-1736
Closed Access | Times Cited: 9
GEARBOCS: An Adeno Associated Virus Tool forIn VivoGene Editing in Astrocytes
Dhanesh Sivadasan Bindu, Justin T Savage, Nicholas Brose, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
CRISPR/Cas-mediated genome editing in mice for the development of drug delivery mechanism
Sowbhagya Ramachandregowda, Harsha Muktha, Thippenahalli Narasimhaiah Ramakrishnaiah, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 9, pp. 7729-7743
Open Access | Times Cited: 4
CRISPR-Cpf1 system and its applications in animal genome editing
Yawei Han, Zisen Jia, Keli Xu, et al.
Molecular Genetics and Genomics (2024) Vol. 299, Iss. 1
Closed Access | Times Cited: 1
CRISPR-Cas9-Mediated NPC1 Gene Deletion Enhances HEK 293 T Cell Adhesion by Regulating E-Cadherin
Zisen Jia, Minlin Yang, Yanchun Zhao, et al.
Molecular Biotechnology (2022) Vol. 65, Iss. 2, pp. 252-262
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top